Know the Lowest Price Act of 2018
USA115th CongressS-2553| Senate
| Updated: 10/10/2018
Debbie Stabenow
Democratic Senator
Michigan
Cosponsors (15)
Dean Heller (Republican)Bill Cassidy (Republican)Catherine Cortez Masto (Democratic)Joe Donnelly (Democratic)Heidi Heitkamp (Democratic)Rand Paul (Republican)Chris Van Hollen (Democratic)Deb Fischer (Republican)Claire McCaskill (Democratic)John Barrasso (Republican)Sherrod Brown (Democratic)Robert Menendez (Democratic)Susan M. Collins (Republican)Rob Portman (Republican)Ron Wyden (Democratic)
Ways and Means Committee, Finance Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Know the Lowest Price Act of 2018 (Sec. 2) This bill prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health-insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text: CR S6033)
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(text: CR S6033)
Measure laid before Senate by unanimous consent. (consideration: CR S6033)
Senate Committee on Finance discharged by Unanimous Consent.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Message on Senate action sent to the House.
Received in the House.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Mr. Burgess moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H8799-8801)
DEBATE - The House proceeded with forty minutes of debate on S. 2553.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8799)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8799)
Motion to reconsider laid on the table Agreed to without objection.
Correct Enrollment
Presented to President.
Signed by President.
Became Public Law No: 115-262.
Health
Health care costs and insuranceHealth care coverage and accessInsurance industry and regulationMedicarePrescription drugs
Know the Lowest Price Act of 2018
USA115th CongressS-2553| Senate
| Updated: 10/10/2018
Know the Lowest Price Act of 2018 (Sec. 2) This bill prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health-insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text: CR S6033)
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(text: CR S6033)
Measure laid before Senate by unanimous consent. (consideration: CR S6033)
Senate Committee on Finance discharged by Unanimous Consent.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Message on Senate action sent to the House.
Received in the House.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Mr. Burgess moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H8799-8801)
DEBATE - The House proceeded with forty minutes of debate on S. 2553.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8799)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8799)
Motion to reconsider laid on the table Agreed to without objection.
Correct Enrollment
Presented to President.
Signed by President.
Became Public Law No: 115-262.
Debbie Stabenow
Democratic Senator
Michigan
Cosponsors (15)
Dean Heller (Republican)Bill Cassidy (Republican)Catherine Cortez Masto (Democratic)Joe Donnelly (Democratic)Heidi Heitkamp (Democratic)Rand Paul (Republican)Chris Van Hollen (Democratic)Deb Fischer (Republican)Claire McCaskill (Democratic)John Barrasso (Republican)Sherrod Brown (Democratic)Robert Menendez (Democratic)Susan M. Collins (Republican)Rob Portman (Republican)Ron Wyden (Democratic)
Ways and Means Committee, Finance Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- SCONRES 115-49: A concurrent resolution providing for a correction in the enrollment of S. 2553.
- HR 115-6144: To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals.
- HR 115-6733: To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices.
- S 115-2554: Patient Right to Know Drug Prices Act
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Health care costs and insuranceHealth care coverage and accessInsurance industry and regulationMedicarePrescription drugs